Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Marking a Decade of Free Antiretroviral Treatment (ART) in India


News provided by

India HIV/AIDS Alliance

07 Apr, 2014, 11:00 IST

Share this article

Share toX

Share this article

Share toX

India HIV/AIDS Alliance (PRNewsFoto/PR NEWSWIRE EUROPE)
India HIV/AIDS Alliance (PRNewsFoto/PR NEWSWIRE EUROPE)

NEW DELHI, April 7, 2014 /PRNewswire/ --

Celebrating the Transformative Commitment of the Government of India to No-cost AIDS Drugs

More than 300 stakeholders from government, affected communities, media, international agencies, and civil society came together today to mark the completion of 10 years of free antiretroviral treatment (ART) in India. The event - Treatment@10 - was organised by the National Coalition of People Living with HIV in India (NCPI+), in collaboration with the Department of AIDS Control, India HIV/AIDS Alliance, PHFI, UNAIDS, USAID and UNDP, to celebrate the 10-year journey that has transformed the lives of people living with HIV (PLHIV) and their families. 

     (Logo: http://photos.prnewswire.com/prnh/20140324/10091843)

The first HIV case in India was detected in 1986. An estimated 2.1 million Indians are now living with the virus. The first effective ART regimens were announced in 1996. Even as the medicines became available in India, they remained unaffordable to most people who needed them. People sold their property and assets to buy the drugs, but few could afford life-long treatment. Mona Balani, a woman living with HIV recalls, "Back in 2002, we were either thrown out or denied treatment at government and private hospitals, and we got no support from our families."

On 1 April 2004, in response to years of advocacy by PLHIV leaders like Ashok Pillai and Rajeshwari, the Government of India began a free ART programme at eight centres in six high-prevalence states that has now grown to a network of 1,251 ART and Link ART centres across India. Today, free ART is accessed by over 768,000 PLHIV at these centres.

Kanjibhai B Gadhia, a farmer from Amreli district of Gujarat who has been on ART for the past 10 years says, "ARV is my partner for life and I can never give it up." His story resonates with the almost eight lakh PLHIV on treatment in India. This 10-year milestone has been made possible by the joint efforts of India's committed PLHIV community, the Department of AIDS Control, bilateral and multilateral donors, and many civil society stakeholders at every level.

While reflecting on progress, the Treatment@10 conference also deliberated on the urgent need to define a clear roadmap to ensure further necessary scale-up of treatment, care and support services for PLHIV in India based on the model of partnership that has defined India's ambitious and innovative model.

Manoj Pardesi, General Secretary, NCPI+, reminded participants, "While the past decade has seen commendable strides in accessibility to AIDS treatment in India, there is still a long way to go. Many people living with the virus are yet to be enrolled in HIV care. PLHIV need routine and uninterrupted access to CD4 testing to ensure timely initiation of ART and regular monitoring. There is an urgent need to scale up viral load testing, enhance accessibility to second and third-line treatment regimens, and increase availability of pediatric formulations. We're committed working with the Department of AIDS Control and other stakeholders to put 10 lakhs PLHIV on treatment by the end of 2015."

Sonal Mehta, Director of Programmes, India HIV/AIDS Alliance added, "Discrimination and stigma continue to be a daily part of the lives of too many PLHIV. India's treatment programme is an example to the world of what can be achieved through committed collaboration. We have learned much in the past decade, and we need to continue to build on this strong foundation. Free ART, coupled with the care and support services provided through the growing network of Vihaan centres, will ensure the vitality and good health of India's PLHIV community and their families for years to come."

About India HIV/AIDS Alliance:

India HIV/AIDS Alliance (Alliance India) is a diverse partnership that brings together committed organisations and communities to support a sustained response to HIV in India. Complementing the national programme in India, we work through capacity building, knowledge sharing, technical support and advocacy. Through our network of partners, Alliance India supports the delivery of effective, innovative, community-based HIV programmes to key groups affected by the epidemic.

About Vihaan:

Vihaan is a national initiative to establish 350 Care & Support Centres (CSCs) across India to provide expanded access to key services, increase treatment adherence, reduce stigma and discrimination, and improve the quality of life of people living with HIV (PLHIV). The programme is designed as the care and support component of the country's HIV response under National AIDS Control Programme IV (NACP IV).

Working in close collaboration with the Department of AIDS Control and with support from the Global Fund, the programme operates in 31 states and territories and will reach more than one million PLHIV by 2016. The Vihaan consortium is led by India HIV/AIDS Alliance and 17 state-level PLHIV networks and NGOs, which in turn partner with district-level PLHIV networks and other organisations to deliver care and support services in communities.

About NCPI+

The National Coalition of People Living with HIV in India (NCPI+) is a national representative body of, for and by people living with HIV (PLHIV). NCPI+ aims to increase the active, transparent and constructive participation of PLHIV and health activists to strengthen care, support and treatment across the country; and improve the quality of life of individuals and families affected by HIV. NCPI+ serves to represent the needs of PLHIV networks and key population CBOs and works with activists to join together to speak with a clear voice, strengthen advocacy, and improve the health and quality of life of PLHIV in India.

For more details, please email [email protected] or visit:

Website: www.allianceindia.org/

Blog: www.indiahivaidsalliance.wordpress.com/

Facebook: www.facebook.com/indiahivaidsalliance

Twitter: www.twitter.com/AllianceinIndia

Media Contact: Sophia Lonappan, [email protected], +91-98-9184-0309, Senior Communications Officer, India HIV/AIDS Alliance

Secondary Media Contact: Bini Philips: +91-95-4062-1333, [email protected], Communications Consultant

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.